Inventor · disambiguated record
Ajay Parashar
Also filed as: PARASHAR AJAY · PARASHAR AJAY P
11 granted patents·19 pending applications·28 citations·filing 2010–2023
88Inventor score
Top patents by PatentIndex Score
30 records- 0189US9061034B2Preservative free bimatoprost and timolol solutionsALLERGAN INC·Filed 2013·Granted Jun 23, 2015·6 cites·8 claims
- 0287US9517219B2Topical dapsone and dapsone/adapalene compositions and methods for use thereofALLERGAN INC·Filed 2015·Granted Dec 13, 2016·4 cites·8 claims
- 0387US9161926B2Topical dapsone and dapsone/adaplene compositions and methods for use thereofALLERGAN INC·Filed 2013·Granted Oct 20, 2015·6 cites·6 claims
- 0486US10058560B2Preservative free bimatoprost and timolol solutionsALLERGAN INC·Filed 2017·Granted Aug 28, 2018·2 cites·8 claims
- 0584US11273132B2Topical dapsone and dapsone/adapalene compositions and methods for use thereofALMIRALL LLC·Filed 2018·Granted Mar 15, 2022·1 cites·1 claims
- 0684US11116733B2Topical dapsone and dapsone/adaplene compositions and methods for use thereofALMIRALL LLC·Filed 2018·Granted Sep 14, 2021·1 cites·14 claims
- 0784US9763958B2Preservative free bimatoprost and timolol solutionsALLERGAN INC·Filed 2015·Granted Sep 19, 2017·2 cites·5 claims
- 0880US9078854B2Preservative free bimatoprost and timolol solutionsLIKITLERSUANG SUKHON·Filed 2011·Granted Jul 14, 2015·6 cites·8 claims
- 0978US2022184002A1Topical dapsone and dapsone/adapalene compositions and methods for use thereofALMIRALL LLC·Filed 2022·Application pending·0 cites
- 1078US2023241030A1Macrogol 15 hydroxystearate formulationsALLERGAN INC·Filed 2023·Application pending·0 cites
- 1170US10792288B2Preservative free brimonidine and timolol solutionsALLERGAN INC·Filed 2019·Granted Oct 6, 2020·0 cites·17 claims
- 1269US2021275497A1Macrogol 15 hydroxystearate formulationsALLERGAN INC·Filed 2021·Application pending·0 cites
- 1364US2017367999A1Topical dapsone and dapsone/adapalene compositions and methods for use thereofALLERGAN INC·Filed 2017·Application pending·0 cites
- 1464US2017360729A1Topical dapsone and dapsone/adapalene compositions and methods for use thereofALLERGAN INC·Filed 2017·Application pending·0 cites
- 1564US2021228587A1Preservative free brimonidine and timolol solutionsALLERGAN INC·Filed 2020·Application pending·0 cites
- 1662US2017087102A1Topical dapsone and dapsone/adapalene compositions and methods for use thereofALLERGAN INC·Filed 2016·Application pending·0 cites
- 1762US2015099807A1Preservative free bimatoprost solutionsALLERGAN INC·Filed 2014·Application pending·0 cites
- 1860US2016243065A1Topical dapsone and dapsone/adaplene compositions and methods for use thereofALLERGAN INC·Filed 2016·Application pending·0 cites
- 1959US10213431B2Preservative free brimonidine and timolol solutionsLIKITLERSUANG SUKHON·Filed 2011·Granted Feb 26, 2019·0 cites·11 claims
- 2057US2014287988A1Macrogol 15 hydroxystearate formulationsALLERGAN INC·Filed 2013·Application pending·0 cites
- 2154US2013005665A1Macrogol 15 hydroxystearate formulationsGORE ANURADHA V·Filed 2012·Application pending·0 cites
- 2251US2013345149A1Silicone-based ophthalmic formulationsALLERGAN INC·Filed 2013·Application pending·0 cites
- 2351US2013245124A1Preservative free bimatoprost solutionsLIKITLERSUANG SUKHON·Filed 2011·Application pending·0 cites
- 2447US2012225952A1Non-aqueous silicone-based ophthalmic formulationsWARNER KEVIN S·Filed 2012·Application pending·0 cites
- 2547US2017266138A1Methods of treatment of acne vulgaris using topical dapsone compositionsALLERGAN INC·Filed 2017·Application pending·0 cites
- 2647US2012225827A1Silicone-based ophthalmic formulationsWARNER KEVIN S·Filed 2012·Application pending·0 cites
- 2745US2017119703A1Methods of treatment of acne vulgaris using topical dapsone compositionsALLERGAN INC·Filed 2016·Application pending·0 cites
- 2841US2016113934A1Preservative free bimatoprost and timolol solutionsALLERGAN INC·Filed 2015·Application pending·0 cites
- 2936US2011178147A1Compositions and methods for controlling pupil dilationALLERGAN INC·Filed 2010·Application pending·0 cites
- 3035US8952051B2Ophthalmic formulations containing substituted gamma lactams and methods for use thereofGORE ANURADHA V·Filed 2010·Granted Feb 10, 2015·0 cites·34 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →